Ministry of National Health Services, Regulations and Coordination

Drug Regulatory Authority of Pakistan

National Control Laboratory for Biologicals

Home Up DBER About Us Contents FAQs WHO LINKS

Measels vaccine

NCLB implements Lot release and Lab testing of Biological Drugs as per Schedule I of DRAP Act, 2012 (Act No. XXI of 2012)

and is part of DRAP Authority under Section 3 of this Act.

2021 is 21st year of service of NCLB


inside nclb left wing nclb enterance inside nclb right wing


Manufactured by NIH, Islamabad WHO TRS
Manufactured by growing measles virus on the SPF eggs. The final product is a purified, stabilized and freeze-dried vaccine. The technical specifications are according to WHO specifications. Requirements for measles, mumps and rubella vaccines and combined vaccine (live)
Technical Report Series, No. 840, 1994, Annex 3
  Measles, mumps and rubella vaccines and combined vaccines, live Title: Requirements for Measles, Mumps and Rubella Vaccines and Combined Vaccines, (Live); Adopted 1992, TRS No 840, Annex 3;
Note TRS No 848
  Position paper
List of Products presently under going Lot Release Performance of NCLB Lot Release system from 2007 onwards  

Home ] Up ]

Send mail to with questions or comments about this web site.
Copyright 2011 National Control Laboratory for Biologicals
Last modified: 13-Jul-2021